| Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis O Gallo, A Franchi, L Magnelli, I Sardi, A Vannacci, V Boddit, V Chiarugi, ... Neoplasia 3 (1), 53-61, 2001 | 429 | 2001 |
| Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer F Cianchi, C Cortesini, P Bechi, O Fantappiè, L Messerini, A Vannacci, ... Gastroenterology 121 (6), 1339-1347, 2001 | 383 | 2001 |
| Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck: Correlation with p53 status, inducible … A Franchi, M Santucci, E Masini, I Sardi, M Paglierani, O Gallo Cancer: Interdisciplinary International Journal of the American Cancer …, 2002 | 256 | 2002 |
| Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis F Cianchi, C Cortesini, O Fantappiè, L Messerini, N Schiavone, ... The American journal of pathology 162 (3), 793-801, 2003 | 212 | 2003 |
| Glioblastoma chemoresistance: the double play by microenvironment and blood-brain barrier M Da Ros, V De Gregorio, AL Iorio, L Giunti, M Guidi, M De Martino, ... International journal of molecular sciences 19 (10), 2879, 2018 | 211 | 2018 |
| A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative … RE Kast, JA Boockvar, A Brüning, F Cappello, WW Chang, B Cvek, ... Oncotarget 4 (4), 502, 2013 | 207 | 2013 |
| Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer F Cianchi, C Cortesini, O Fantappie, L Messerini, I Sardi, N Lasagna, ... Clinical Cancer Research 10 (8), 2694-2704, 2004 | 205 | 2004 |
| Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma L Gandola, M Massimino, G Cefalo, C Solero, F Spreafico, E Pecori, ... Journal of Clinical Oncology 27 (4), 566-571, 2009 | 189 | 2009 |
| Exposure to global system for mobile communication (GSM) cellular phone radiofrequency alters gene expression, proliferation, and morphology of human skin fibroblasts S Pacini, M Ruggiero, I Sardi, S Aterini, F Gulisano, M Gulisano Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 13 …, 2002 | 179 | 2002 |
| Focal genomic amplification at 19q13. 42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes A Korshunov, M Remke, M Gessi, M Ryzhova, T Hielscher, H Witt, ... Acta neuropathologica 120, 253-260, 2010 | 170 | 2010 |
| Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood M Massimino, V Biassoni, R Miceli, E Schiavello, M Warmuth-Metz, ... Journal of neuro-oncology 118, 305-312, 2014 | 141 | 2014 |
| Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma M Massimino, R Miceli, F Giangaspero, L Boschetti, P Modena, ... Neuro-oncology 18 (10), 1451-1460, 2016 | 136 | 2016 |
| Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions D Massi, A Franchi, I Sardi, L Magnelli, M Paglierani, L Borgognoni, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001 | 123 | 2001 |
| The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD) R Abbate, I Sardi, G Pepe, R Marcucci, T Brunelli, D Prisco, C Fatini, ... Thrombosis and haemostasis 79 (04), 727-730, 1998 | 120 | 1998 |
| The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line O Fantappiè, E Masini, I Sardi, L Raimondi, D Bani, M Solazzo, ... Hepatology 35 (4), 843-852, 2002 | 117 | 2002 |
| Effect of 0.2 T static magnetic field on human neurons: remodeling and inhibition of signal transduction without genome instability S Pacini, GB Vannelli, T Barni, M Ruggiero, I Sardi, P Pacini, M Gulisano Neuroscience letters 267 (3), 185-188, 1999 | 115 | 1999 |
| Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma O Gallo, N Schiavone, L Papucci, I Sardi, L Magnelli, A Franchi, E Masini, ... The american journal of pathology 163 (2), 723-732, 2003 | 107 | 2003 |
| Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors G Golinelli, G Grisendi, M Prapa, M Bestagno, C Spano, F Rossignoli, ... Cancer gene therapy 27 (7), 558-570, 2020 | 98 | 2020 |
| A lower-dose, lower-toxicity cisplatin–etoposide regimen for childhood progressive low-grade glioma M Massimino, F Spreafico, D Riva, V Biassoni, G Poggi, C Solero, ... Journal of neuro-oncology 100, 65-71, 2010 | 88 | 2010 |
| Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series MR Raspollini, I Sardi, L Giunti, S Di Lollo, G Baroni, N Stomaci, ... Human pathology 42 (8), 1149-1158, 2011 | 73 | 2011 |
